San Diego, CA -- (SBWIRE) -- 02/13/2019 -- An investigation was announced concerning potential securities laws violations by Akorn, Inc. and certain of its directors and officers in connection with certain financial statements.

Investors who purchased shares of Akorn, Inc. (NASDAQ: AKRX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Akorn, Inc. (NASDAQ: AKRX) concerning whether a series of statements by Akorn, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Lake Forest, IL based Akorn, Inc., a specialty generic pharmaceutical company, develops, manufactures, and markets generic and branded prescription pharmaceuticals, over-the-counter (OTC) consumer health products, and animal health pharmaceuticals in the United States and internationally. On January 9, 2019, Akorn, Inc. disclosed that it had received a warning letter from the U.S. Food and Drug Administration following an inspection of Akorn's Decatur, Illinois manufacturing facility. This inspection revealed that contrary to Akorn's representations to shareholders, Akorn had failed to comply with multiple federal regulations pertaining to drug manufacturing.

Those who purchased shares of Akorn, Inc. (NASDAQ: AKRX) have certain options and should contact the Shareholders Foundation.

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com